Dissection of the host-pathogen interaction in human tuberculosis using a bioengineered 3-dimensional model

  1. Liku B Tezera  Is a corresponding author
  2. Magdalena K Bielecka
  3. Andrew Chancellor
  4. Michaela T Reichmann
  5. Basim Al Shammari
  6. Patience Brace
  7. Alex Batty
  8. Annie Tocheva
  9. Sanjay Jogai
  10. Ben G Marshall
  11. Marc Tebruegge
  12. Suwan N Jayasinghe
  13. Salah Mansour
  14. Paul T Elkington  Is a corresponding author
  1. University of Southampton, United Kingdom
  2. King Abdullah International Medical Research Center, Saudi Arabia
  3. University College London, United Kingdom

Abstract

Cell biology differs between traditional cell culture and 3-dimensional (3-D) systems, and is modulated by the extracellular matrix. Experimentation in 3-D presents challenges, especially with virulent pathogens. Mycobacterium tuberculosis (Mtb) kills more humans than any other infection and is characterised by a spatially organised immune response and extracellular matrix remodelling. We developed a 3-D system incorporating virulent mycobacteria, primary human blood mononuclear cells and collagen-alginate matrix to dissect the host-pathogen interaction. Infection in 3-D led to greater cellular survival and permitted longitudinal analysis over 21 days. Key features of human tuberculosis develop, and extracellular matrix integrity favours the host over the pathogen. We optimised multiparameter readouts to study emerging therapeutic interventions: cytokine supplementation, host-directed therapy and immunoaugmentation. Each intervention modulates the host-pathogen interaction, but has both beneficial and harmful effects. This methodology has wide applicability to investigate infectious, inflammatory and neoplastic diseases and develop novel drug regimes and vaccination approaches.

Article and author information

Author details

  1. Liku B Tezera

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    For correspondence
    l.tezera@soton.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
  2. Magdalena K Bielecka

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Andrew Chancellor

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Michaela T Reichmann

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Basim Al Shammari

    King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
    Competing interests
    The authors declare that no competing interests exist.
  6. Patience Brace

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Alex Batty

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Annie Tocheva

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Sanjay Jogai

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Ben G Marshall

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Marc Tebruegge

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  12. Suwan N Jayasinghe

    BioPhysics Group, UCL Institute of Biomedical Engineering, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  13. Salah Mansour

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  14. Paul T Elkington

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    For correspondence
    p.elkington@soton.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0390-0613

Funding

Medical Research Council (MR/N006631/1)

  • Paul T Elkington

National Institute of Allergy and Infectious Diseases (R33AI102239)

  • Suwan N Jayasinghe
  • Paul T Elkington

National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC/L001039/1)

  • Liku B Tezera
  • Paul T Elkington

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Bree Aldridge, Tufts University School of Medicine, United States

Ethics

Human subjects: For analysis of blood from healthy donors and healthy TB exposed individuals, this work was approved by the National Research Ethics Service committee South Central - Southampton A, study title 'An investigation into the immune response to tuberculosis infection and development of novel diagnostic markers', reference 13/SC/0043. All donors gave written informed consent. For histological analysis, samples used in this study were sourced from the Southampton Research Biorepository, University Hospital Southampton NHS Foundation Trust and University of Southampton, Mailpoint 218, Tremona Road, Southampton, SO16 6YD. Lung biopsy tissue was taken as part of routine clinical care and tissue blocks excess to diagnostic testing were analyzed in this study. The project was approved by the Institutional Review Board (Reference 12/NW/0794 SRB04_14). The ethics committee approved the analysis of this tissue without individual informed consent since it was surplus archived tissue taken as part of routine care.

Version history

  1. Received: September 6, 2016
  2. Accepted: January 5, 2017
  3. Accepted Manuscript published: January 7, 2017 (version 1)
  4. Version of Record published: January 16, 2017 (version 2)
  5. Version of Record updated: August 8, 2017 (version 3)

Copyright

© 2017, Tezera et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,769
    views
  • 873
    downloads
  • 54
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Liku B Tezera
  2. Magdalena K Bielecka
  3. Andrew Chancellor
  4. Michaela T Reichmann
  5. Basim Al Shammari
  6. Patience Brace
  7. Alex Batty
  8. Annie Tocheva
  9. Sanjay Jogai
  10. Ben G Marshall
  11. Marc Tebruegge
  12. Suwan N Jayasinghe
  13. Salah Mansour
  14. Paul T Elkington
(2017)
Dissection of the host-pathogen interaction in human tuberculosis using a bioengineered 3-dimensional model
eLife 6:e21283.
https://doi.org/10.7554/eLife.21283

Share this article

https://doi.org/10.7554/eLife.21283

Further reading

    1. Chromosomes and Gene Expression
    2. Immunology and Inflammation
    Rajan M Thomas, Matthew C Pahl ... Andrew D Wells
    Research Article

    Ikaros is a transcriptional factor required for conventional T cell development, differentiation, and anergy. While the related factors Helios and Eos have defined roles in regulatory T cells (Treg), a role for Ikaros has not been established. To determine the function of Ikaros in the Treg lineage, we generated mice with Treg-specific deletion of the Ikaros gene (Ikzf1). We find that Ikaros cooperates with Foxp3 to establish a major portion of the Treg epigenome and transcriptome. Ikaros-deficient Treg exhibit Th1-like gene expression with abnormal production of IL-2, IFNg, TNFa, and factors involved in Wnt and Notch signaling. While Ikzf1-Treg-cko mice do not develop spontaneous autoimmunity, Ikaros-deficient Treg are unable to control conventional T cell-mediated immune pathology in response to TCR and inflammatory stimuli in models of IBD and organ transplantation. These studies establish Ikaros as a core factor required in Treg for tolerance and the control of inflammatory immune responses.

    1. Evolutionary Biology
    2. Immunology and Inflammation
    Mark S Lee, Peter J Tuohy ... Michael S Kuhns
    Research Advance

    CD4+ T cell activation is driven by five-module receptor complexes. The T cell receptor (TCR) is the receptor module that binds composite surfaces of peptide antigens embedded within MHCII molecules (pMHCII). It associates with three signaling modules (CD3γε, CD3δε, and CD3ζζ) to form TCR-CD3 complexes. CD4 is the coreceptor module. It reciprocally associates with TCR-CD3-pMHCII assemblies on the outside of a CD4+ T cells and with the Src kinase, LCK, on the inside. Previously, we reported that the CD4 transmembrane GGXXG and cytoplasmic juxtamembrane (C/F)CV+C motifs found in eutherian (placental mammal) CD4 have constituent residues that evolved under purifying selection (Lee et al., 2022). Expressing mutants of these motifs together in T cell hybridomas increased CD4-LCK association but reduced CD3ζ, ZAP70, and PLCγ1 phosphorylation levels, as well as IL-2 production, in response to agonist pMHCII. Because these mutants preferentially localized CD4-LCK pairs to non-raft membrane fractions, one explanation for our results was that they impaired proximal signaling by sequestering LCK away from TCR-CD3. An alternative hypothesis is that the mutations directly impacted signaling because the motifs normally play an LCK-independent role in signaling. The goal of this study was to discriminate between these possibilities. Using T cell hybridomas, our results indicate that: intracellular CD4-LCK interactions are not necessary for pMHCII-specific signal initiation; the GGXXG and (C/F)CV+C motifs are key determinants of CD4-mediated pMHCII-specific signal amplification; the GGXXG and (C/F)CV+C motifs exert their functions independently of direct CD4-LCK association. These data provide a mechanistic explanation for why residues within these motifs are under purifying selection in jawed vertebrates. The results are also important to consider for biomimetic engineering of synthetic receptors.